InvestorsHub Logo
Followers 9
Posts 250
Boards Moderated 0
Alias Born 03/16/2017

Re: None

Friday, 04/20/2018 6:51:36 PM

Friday, April 20, 2018 6:51:36 PM

Post# of 64422
For those who persistently try to undermine our EuroAmerican IP and NXGen distributors based on "years in business" or size alone....



Check out our previous distributor for Nyloxin (then called Cobroxin) product in 2009 / 2010:


At the time, the product was in CVS, Walgreens, and many other retail brick and mortor stores... However, due to a breach of contract by the distributor, Nutrapharma severed the relationship in 2011... and yes, at the time, the distributor was new to business with few employees.... but nonetheless, Nutrapharma stock was trading at $1 with a market cap of 220 million <adjusted for the 1/40 stock split on 05/18/15>... execution trumps time on the job any day... refer to Bill Gates, Steve Jobs, and Mark Zukkenburg as examples.

However, once the gsa approves and more retail contracts are established this market cap will seem marginal VERY SOON!!!... add in the mix any announcement of a JV partnership and the pursuit of more clinical trials and our stock price could be multi dimes / quarters EVEN SOONER!

...and here we sit at approximately a market cap of 50Xs less than previous years with hundreds of times more potential.

Xenacare distributor

Cobroxin in Walgreens

Cobroxin in CVS